Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis

Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis

The preferred antithrombotic strategy for secondary prevention in patients with cryptogenic stroke (CS) and patent foramen ovale (PFO) is unknown. We pooled multiple observational studies and used propensity score-based methods to estimate the comparative effectiveness of oral anticoagulation (OAC)...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: David M. Kent, Issa J Dahabreh, Robin Ruthazer, Anthony J. Furlan, Christian Weimar, Joaquı́n Serena, Bernhard Meier, Heinrich P. Mattle, Emanuele Di Angelantonio, Maurizio Paciaroni, Herwig Schuchlenz, Shunichi Homma, Jennifer S. Lutz, David E. Thaler
Médium: Revisão
Jazyk:angličtina
Vydáno: 2015
On-line přístup:https://doi.org/10.1093/eurheartj/ehv252
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

https://doi.org/10.1093/eurheartj/ehv252

Podobné jednotky